Optimal anticoagulant treatment of cancer-associated venous thromboembolism remains unclear

被引：1
|
作者：
Al-Samkari, Hanny [1 ]
机构：
[1] Harvard Univ, Massachusetts Gen Hosp, Div Hematol, Med Sch, Boston, MA 02114 USA
来源：
BMJ EVIDENCE-BASED MEDICINE | 2019年 / 24卷 / 03期
关键词：
D O I：
10.1136/bmjebm-2018-111096
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：115 / 116
页数：2
相关论文
共 50 条
  • [21] Treatment modalities in cancer-associated venous thromboembolism (VTE)
    Soto Alsar, Javier
    Ortiz de la Tabla, Ana Gutierrez
    Ortega Moran, Laura
    Munoz Martin, Andres J.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2022, 35 (01)
  • [22] Cancer-associated venous thromboembolism: Treatment and prevention with rivaroxaban
    Bauersachs, Rupert
    Khorana, Alok A.
    Lee, Agnes Y. Y.
    Soff, Gerald
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2020, 4 (04) : 532 - 549
  • [23] Current status of treatment of cancer-associated venous thromboembolism
    Xiong, Wei
    THROMBOSIS JOURNAL, 2021, 19 (01)
  • [24] Prevention and Treatment of Cancer-Associated Venous Thromboembolism: a Review
    Sanfilippo, Kristen M.
    Wang, Tzu-Fei
    CURRENT TREATMENT OPTIONS IN CARDIOVASCULAR MEDICINE, 2019, 21 (11)
  • [25] Safety of stopping anticoagulant treatment for cancer-associated venous thromboembolism after reaching complete remission from cancer
    Hulle, T. V. D.
    den Exter, P. L.
    van den Hoven, P.
    van der Hoeven, J. J.
    van der Meer, F. J.
    Eikenboom, J.
    Huisman, M., V
    Klok, F. A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 987 - 987
  • [26] An answer to "anticoagulant treatment of cancer-associated venous thromboembolism: Interpreting real-world data with caution"
    Streiff, Michael B.
    Milentijevic, Dejan
    McCrae, Keith
    Yannicelli, Daniel
    Lejeune, Dominique
    Nelson, Winnie W.
    Laliberte, Francois
    Crivera, Concetta
    Lefebvre, Patrick
    Schein, Jeff
    Khorana, Alok A.
    AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (09) : E225 - E227
  • [27] Edoxaban for Cancer-Associated Venous Thromboembolism
    Nasser, Nicola J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (01): : 94 - +
  • [28] Rivaroxaban for cancer-associated venous thromboembolism
    Liang, Bo
    Liang, Yi
    Zhao, Li-Zhi
    Zhao, Yu-Xiu
    Gu, Ning
    SCIENCE PROGRESS, 2021, 104 (02)
  • [29] Incidence of cancer-associated venous thromboembolism
    Ballardini, P.
    Zangirolami, A.
    Margutti, G.
    Manfredini, R.
    ANNALS OF ONCOLOGY, 2006, 17 : XI70 - XI71
  • [30] Direct oral anticoagulants in the treatment of cancer-associated venous thromboembolism
    Yhim, Ho-Young
    Bang, Soo-Mee
    BLOOD RESEARCH, 2014, 49 (02) : 77 - 79
12345